Results 111 to 120 of about 8,517,970 (127)

Real-world pharmacovigilance of drug-related bone metabolism disorders: integrating FAERS and VigiAccess with a Bradford Hill-based causal plausibility assessment. [PDF]

Front Pharmacol
Liu P, Zhao K, Zhang H, Liu MQ, Li J, Sun Y.   +5 more
europepmc   +1 more source

Comparative real-world safety profiles of caspofungin, micafungin, and anidulafungin: a disproportionality analysis based on FAERS and VigiAccess databases. [PDF]

Front Pharmacol
Chen J, Chen C, Lin X, Yan J, Zheng Y, Chen P, Li J.   +6 more
europepmc   +1 more source

Adverse events of givosiran in the treatment of acute hepatic porphyria: a pharmacovigilance study using the FAERS and VigiAccess databases. [PDF]

Orphanet J Rare Dis
Xu Y, Li F, Huang L, Zhang M, Du P.
europepmc   +1 more source

Post-marketing safety signals of Wilson's disease therapies: evidence from FAERS and VigiBase. [PDF]

Orphanet J Rare Dis
Tezel-Yalçın H, Yalçın N, Allegaert K, Erkekoğlu P.   +3 more
europepmc   +1 more source

Adverse event profile of fondaparinux sodium: a disproportionality analysis based on FAERS, JADER, and VigiAccess databases. [PDF]

Front Med (Lausanne)
Jin W, Pan J, Yu L, Zhu M.
europepmc   +1 more source

Real-world study of adverse events associated with sodium zirconium cyclosilicate based on FDA adverse event reporting system and VigiAccess database. [PDF]

PLoS One
Jia X, Liu L, Wang P.
europepmc   +1 more source

Adverse Events Following Immunization Associated With Coronavirus Disease 2019 (COVID-19) Vaccines: A Descriptive Analysis From VigiAccess

Human Vaccines and Immunotherapeutics, 2022
This study assessed adverse events following immunizations (AEFIs) reported on COVID-19 vaccines in VigiAccess and determined the reporting trends across all continents of the world. The study was cross-sectional quantitative in design.
Joseph Attakorah, Peter Yamoah, Neelaveni Padayachee   +2 more
exaly   +2 more sources

Interstitial Lung Disease Induced by Fluoxetine: Systematic Review of Literature and Analysis of Vigiaccess, Eudravigilance and a National Pharmacovigilance Database

Pharmacological Research, 2017
We investigated a pulmonary adverse drug reaction possibly induced by fluoxetine, the Interstitial Lung Disease, by performing a systematic review of published case reports on this subject, a review of the World Health Organization VigiAccess database ...
Maria Del Zompo, Claudia Pisanu, Alberto Bocchetta   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Adverse events following the use of immune checkpoint inhibitors: An analysis of the WHO VigiAccess database.

Journal of Clinical Oncology, 2019
e13118 Background: Immune checkpoint inhibitors (ICIs), especially ipilimumab (ipi) and nivolumab (nivo), have received approvals from the U.S. Food and Drug Administration for the treatment of multiple tumor types. These medications have shown great promise in the treatment of several malignancies but are associated with immune-related adverse ...
Nikita Nikita, Ralph Zinner, Jennifer Maria Johnson, Natasha Ghosh, Melissa Wilson, Grace L. Lu-Yao   +5 more
openaire   +1 more source

Analysis of Adverse Event Reporting Patterns Following COVID-19 Vaccination: Findings From VigiAccess, FAERS and EudraVigilance Databases With Comparative Assessment of Data Representation and Categorization Across Three Databases [PDF]

International Journal of Basic and Clinical Pharmacology
The clinical presentation of COVID-19 varied from mild to severe or fatal illness, and vaccination played a pivotal role in preventing the spread of severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2). Despite cumulative evidence suggesting that
Bhave, Kiran A., Pandit, Prasad R., Mahurkar, Ram N., Patel, Tejal C.   +3 more
exaly   +2 more sources